MELISSA RENZI: Open Payments
NPI 1912498767 · FLOURTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,721 in 133 payments from 19 companies in 2025. Trend: 2023 $2,390 · 2024 $2,322 · 2025 $2,721
Food & beverage: $2,527Education: $194
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $575 |
| ABBVIE INC. | 28 | $432 |
| LEO Pharma Inc. | 15 | $281 |
| GENZYME CORPORATION | 7 | $220 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $199 |
| Lilly USA, LLC | 9 | $165 |
| Novartis Pharmaceuticals Corporation | 8 | $156 |
| Galderma Laboratories, L.P. | 9 | $141 |
| Regeneron Healthcare Solutions, Inc. | 5 | $111 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, ADBRY, RINVOQ, COSENTYX, TALTZ, NEMLUVIO.
Industry payments across PA — which companies pay providers there.
